Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 11:11:594042.
doi: 10.3389/fphar.2020.594042. eCollection 2020.

Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation

Affiliations
Review

Regulating Gut Microbiome: Therapeutic Strategy for Rheumatoid Arthritis During Pregnancy and Lactation

Yao Yao et al. Front Pharmacol. .

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation and bone destruction. Microbial infection is considered to be the most important inducement of RA. The pregnancy planning of women in childbearing age is seriously affected by the disease activity of RA. Gut microbiome, related to immunity and inflammatory response of the host. At present, emerging evidence suggested there are significant differences in the diversity and abundance of gut microbiome during pregnancy and lactation, which may be associated with the fluctuation of RA disease activity. Based on these research foundations, we pioneer the idea of regulating gut microbiome for the treatment of RA during pregnancy and lactation. In this review, we mainly introduce the potential treatment strategies for controlling the disease activity of RA based on gut microbiome during pregnancy and lactation. Besides, we also briefly generalize the effects of conventional anti-rheumatic drugs on gut microbiome, the effects of metabolic changes during pregnancy on gut microbiome, alteration of gut microbiome during pregnancy and lactation, and the effects of anti-rheumatic drugs commonly used during pregnancy and lactation on gut microbiome. These will provide a clear knowledge framework for researchers in immune-related diseases during pregnancy. Regulating gut microbiome may be a potential and effective treatment to control the disease activity of RA during pregnancy and lactation.

Keywords: gut microbiome; lactation; pregnancy; rheumatoid arthritis; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Gut microbiome in the etiology of Rheumatoid arthritis (RA). The etiology of RA is mainly related to environmental factors and genetic factors. Among the environmental factors, smoking, infection and dust can affect the structure of gut microbiome to participate in the occurrence and development of RA. Among genetic factors, the composition of gut microbiome is associated with genotype and sex, which is linked to the occurrence and development of RA. Therefore, gut microbiome play an important role in the etiology of RA.
FIGURE 2
FIGURE 2
Possible mechanisms of gut microbiome in Rheumatoid arthritis (RA) during pregnancy and lactation. The fluctuation of disease activity of RA during pregnancy and lactation may be affected by gut microbiome. The possible mechanisms are as follows: 1) The ability to produce citrullinization of peptides by enzymatic action. 2) Activation of antigenpresenting cells through an effect on Toll-like receptors or Nod-like receptors. 3) Antigenic mimicry 4) Control of host immune system (triggering T cell differentiation). 5) Alterations in permeability of intestinal mucosal. 6) Increase of T helper type 17-mediated mucosal inflammation.

Similar articles

Cited by

References

    1. Abdollahi-Roodsaz S., Abramson S. B., Scher J. U. (2016). The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nat. Rev. Rheumatol. 12 (8), 446–455. 10.1038/nrrheum.2016.68 - DOI - PubMed
    1. Agorastos A., Bozikas V. P. (2019). Gut microbiome and adaptive immunity in schizophrenia. Psychiatriki 30 (3), 189–192. 10.22365/jpsych.2019.303.189 - DOI - PubMed
    1. Amariuta T., Luo Y., Knevel R., Okada Y., Raychaudhuri S. (2020). Advances in genetics toward identifying pathogenic cell states of rheumatoid arthritis. Immunol. Rev. 294 (1), 188–204. 10.1111/imr.12827 - DOI - PMC - PubMed
    1. Angelakis E., Million M., Kankoe S., Lagier J. C., Armougom F., Giorgi R., et al. (2014). Abnormal weight gain and gut microbiota modifications are side effects of long-term doxycycline and hydroxychloroquine treatment. Antimicrob. Agents Chemother. 58 (6), 3342–3347. 10.1128/AAC.02437-14 - DOI - PMC - PubMed
    1. Badsha H. (2018). Role of diet in influencing rheumatoid arthritis disease activity. Open Rheumatol. J. 12, 19–28. 10.2174/1874312901812010019 - DOI - PMC - PubMed

LinkOut - more resources